A novel splicing variant form suppresses the activity of full-length signal transducer and activator of transcription 5A

FEBS Journal

Volumn 276, Issue 21, 2009, Pages 6312-6323

  Watanabe, Yoshihisa ^a   Ikegawa, Masaya ^a   Naruse, Yoshihisa ^b   Tanaka, Masaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

Author keywords

Brainstem; Coaggregation; STAT5A splicing variant; Suppression of STAT5A activity

Indexed keywords

COMPLEMENTARY DNA; PROLACTIN; PROLINE; SERINE; STAT5A PROTEIN; THREONINE;

ANIMAL TISSUE; ARTICLE; BRAIN STEM; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CEREBELLUM; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE DELETION; GENE REPRESSION; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LUNG; MOLECULAR CLONING; NERVE GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; THYMUS; TISSUE DISTRIBUTION; TRANSACTIVATION;

ANIMALS; HELA CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; STAT5 TRANSCRIPTION FACTOR;

EID: 70349961479     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07339.x     Document Type: Article

References (33)

1. Darnell JE Jr., Kerr IM Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415 1421.
2. Levy DE Darnell JE Jr. (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3, 651 662.
3. Ihle JN (1996) STATs: signal transducers and activators of transcription. Cell 84, 331 334.
4. Hoey T Schindler U (1998) STAT structure and function in signaling. Curr Opin Genet Dev 8, 582 587.
5. John S, Vinkemeier U, Soldaini E, Darnell JE Jr. Leonard WJ (1999) The significance of tetramerization in promoter recruitment by Stat5. Mol Cell Biol 19, 1910 1918.
6. Brockman JL, Schroeder MD Schuler LA (2002) PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. Mol Endocrinol 16, 774 784.
7. O'Shea JJ (1997) Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7, 1 11.
8. Markham K, Schuurmans C Weiss S (2007) STAT5A/B activity is required in the developing forebrain and spinal cord. Mol Cell Neurosci 35, 272 282.
9. Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, Torisu T, Chien KR, Yasukawa H Yoshimura A (2004) Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 10, 739 743.
10. Lee JY, Muenzberg H, Gavrilova O, Reed JA, Berryman D, Villanueva EC, Louis GW, Leinninger GM, Bertuzzi S, Seeley RJ et al. (2008) Loss of cytokine-STAT5 signaling in the CNS and pituitary gland alters energy balance and leads to obesity. PLoS ONE 3, e1639.
11. Tanaka M, Iijima N, Miyamoto Y, Fukusumi S, Itoh Y, Ozawa H Ibata Y (2005) Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. Eur J Neurosci 21, 1659 1670.
12. McGowan BM, Stanley SA, Smith KL, White NE, Connolly MM, Thompson EL, Gardiner JV, Murphy KG, Ghatei MA Bloom SR (2005) Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146, 3295 3300.
13. Miyamoto Y, Watanabe Y Tanaka M (2008) Developmental expression and serotonergic regulation of relaxin 3/INSL7 in the nucleus incertus of rat brain. Regul Pept 145, 54 59.
14. Tanaka M, Watanabe Y Yoshimoto K (2009) Regulation of relaxin 3 gene expression via cAMP-PKA in a neuroblastoma cell line. J Neurosci Res 87, 820 829.
15. Kline JB, Roehrs H Clevenger CV (1999) Functional characterization of the intermediate isoform of the human prolactin receptor. J Biol Chem 274, 35461 35468.
16. Fang F, Antico G, Zheng J Clevenger CV (2008) Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter. BMC Biotechnol 8, 11.
17. Lim CP Cao X (2006) Structure, function, and regulation of STAT proteins. Mol Biosyst 2, 536 550.
18. Wang D, Stravopodis D, Teglund S, Kitazawa J Ihle JN (1996) Naturally occurring dominant negative variants of Stat5. Mol Cell Biol 16, 6141 6148.
19. Meyer J, Jücker M, Ostertag W Stocking C (1998) Carboxyl-truncated STAT5β is generated by a nucleus-associated serine protease in early hematopoietic progenitors. Blood 91, 1901 1908.
20. Yamashita H, Iwase H, Toyama T Fujii Y (2003) Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells. Oncogene 22, 1638 1652.
21. Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JA, Lammers JW, Koenderman L de Groot RP (1996) STAT3β, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 271, 13221 13227.
22. Neculai D, Neculai AM, Verrier S, Straub K, Klumpp K, Pfitzner E Becker S (2005) Structure of the unphosphorylated STAT5a dimer. J Biol Chem 280, 40782 40787.
23. Azam M, Erdjument-Bromage H, Kreider BL, Xia M, Quelle F, Basu R, Saris C, Tempst P, Ihle JN Schindler C (1995) lnterleukin-3 signals through multiple isoforms of Stat5. EMBO J 14, 1402 1411.
24. Oberdoerffer S, Moita LF, Neems D, Freitas RP, Hacohen N Rao A (2008) Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Science 321, 686 691.
25. Mütze J, Roth J, Gerstberger R Hübschle T (2007) Nuclear translocation of the transcription factor STAT5 in the rat brain after systemic leptin administration. Neurosci Lett 417, 286 291.
26. Lansbury PT Lashuel HA (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443, 774 779.
27. Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10, 524 530.
28. Li SH Li XJ (2004) Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet 20, 146 154.
29. Yamanaka T, Miyazaki H, Oyama F, Kurosawa M, Washizu C, Doi H Nukina N (2008) Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor. EMBO J 27, 827 839.
30. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A et al. (2003) Growth hormone insensitivity associated with a STAT5b mutation. New Engl J Med 349, 1139 1147.
31. Hwa V, Little B, Adiyaman P, Kofoed EM, Pratt KL, Ocal G, Berberoglu M Rosenfeld RG (2005) Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab 90, 4260 4266.
32. Xu B, Kitawaki J, Koshiba H, Ishihara H, Kiyomizu M, Teramoto M, Kitaoka Y Honjo H (2007) Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells. Maturitas 56, 142 152.
33. Watanabe Y, Okui A, Mitsui S, Kawarabuki K, Yamaguchi T, Uemura H Yamaguchi N (2004) Molecular cloning and tissue-specific expression analysis of mouse spinesin, a type II transmembrane serine protease 5. Biochem Biophys Res Commun 324, 333 340.